Shuttle Pharmaceuticals ... (SHPH)
Shuttle Pharmaceuticals Statistics
Share Statistics
Shuttle Pharmaceuticals has 6.26M shares outstanding. The number of shares has increased by -78.18% in one year.
| Shares Outstanding | 6.26M |
| Shares Change (YoY) | -78.18% |
| Shares Change (QoQ) | 24.4% |
| Owned by Institutions (%) | 0.52% |
| Shares Floating | 4.19M |
| Failed to Deliver (FTD) Shares | 222 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 702.63K, so 17.24% of the outstanding shares have been sold short.
| Short Interest | 702.63K |
| Short % of Shares Out | 17.24% |
| Short % of Float | 23.05% |
| Short Ratio (days to cover) | 0.25 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Shuttle Pharmaceuticals's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Shuttle Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 2.33.
| Current Ratio | 1.44 |
| Quick Ratio | 1.44 |
| Debt / Equity | 2.33 |
| Total Debt / Capitalization | 69.96 |
| Cash Flow / Debt | -4.44 |
| Interest Coverage | 885.43 |
Financial Efficiency
Return on equity (ROE) is -12.9% and return on capital (ROIC) is -326.01%.
| Return on Equity (ROE) | -12.9% |
| Return on Assets (ROA) | -3.65% |
| Return on Capital (ROIC) | -326.01% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,016,088,555.56 |
| Employee Count | 9 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -88.69% in the last 52 weeks. The beta is 0.29, so Shuttle Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 0.29 |
| 52-Week Price Change | -88.69% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 35.85 |
| Average Volume (20 Days) | 136.5K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -7.7B |
| Net Income | -9.14B |
| EBITDA | -7.7B |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3186.21 |
Balance Sheet
The company has 1.92B in cash and 1.65B in debt, giving a net cash position of 268.55M.
| Cash & Cash Equivalents | 1.92B |
| Total Debt | 1.65B |
| Net Cash | 268.55M |
| Retained Earnings | -34.58B |
| Total Assets | 2.51M |
| Working Capital | 677.15K |
Cash Flow
In the last 12 months, operating cash flow was -7.33B and capital expenditures 0, giving a free cash flow of -7.33B.
| Operating Cash Flow | -7.33B |
| Capital Expenditures | 0 |
| Free Cash Flow | -7.33B |
| FCF Per Share | -2552.94 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SHPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -838476.32% |
| FCF Yield | -308054.62% |
Analyst Forecast
Currently there are no analyst rating for SHPH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 13, 2024. It was a backward split with a ratio of 1:8.
| Last Split Date | Aug 13, 2024 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -28.44 |
| Piotroski F-Score | 3 |